CDKN2A and neoplasm: We analysed tumour characteristics, lifestyle- and patient-related risk factors for patients with “truly” HPV-negative (HPV–DNA-negative and p16INK4a-negative) and HPV16-driven (HPV16–DNA-positive and p16INK4a-positive) OPSCC.